openPR Logo
Press release

Capsule OTC Analgesics Market: Projection of Each Major Segment over the Forecast Period 2022 - 2032

05-09-2022 07:52 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

According to Fact MR's recent market research, sales of Capsule OTC Analgesics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Capsule OTC Analgesics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain 'ahead' of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=75

As per the latest industry analysis published by Fact.MR, the global OTC analgesics market was valued at around US$ 25 Bn in 2020, and is expected to accelerate at a CAGR of 5% through 2031. Demand for nonsteroidal anti-inflammatory drugs (NSAIDs) is set to increase at a CAGR of 4% across the assessment period of 2021 to 2031. Overall, the worldwide Over the Counter analgesics market is projected to expand 1.6X and top a valuation of US$ 40 Bn by 2031.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Capsule OTC Analgesics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Capsule OTC Analgesics

The report offers actionable and valuable market insights of Capsule OTC Analgesics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Capsule OTC Analgesics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Capsule OTC Analgesics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Capsule OTC Analgesics Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=75

Key Market Segments in OTC Analgesics Industry Research
By Form :
• OTC Analgesic Tablets
• OTC Analgesic Capsules
• OTC Analgesic Liquid

By Drug Type :
• OTC Acetaminophen
• OTC Salicylates
• OTC Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

By OTC Channel :
• Sales of OTC Analgesics at Pharmacies
• Sales of OTC Analgesics at Drug Stores
• Online Sales of OTC Analgesics
• Modern Trade Sales of OTC Analgesics

7 Prospects of the Global OTC Analgesics Market
• In terms of revenues, North America is expected to hold the largest share of the market, and will remain dominant in the global market for OTC analgesics over the forecast period.
• Europe will continue to be the second largest market for OTC analgesics, while the market in Japan is expected to register a relatively higher CAGR than the market in Europe through 2022.
• Pharmacy is expected to be the most lucrative OTC channel for OTC analgesics in the global market, followed by drug store and online store.
• Sales of OTC analgesics in online store and modern trade OTC channels are anticipated to register the highest CAGRs through 2022.
• In terms of revenues, tablet form of OTC analgesics is estimated to account for more than half share of the market throughout the forecast period. Tablet OTC analgesics will continue to be sought-after among consumers across the globe.
• Capsule is expected to remain the second largest adopted product form of OTC analgesics in the market, with sales exhibiting the highest CAGR through 2022.
• Key market players profiled in Fact.MR's report on the global market for OTC analgesics include Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., GlaxoSmithKline Plc., Novartis AG, AstraZeneca Plc., Sun Pharmaceuticals Industries Limited, and Pfizer Inc.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/75

Report Benefits & Key Questions Answered
• Capsule OTC Analgesics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
• Capsule OTC Analgesics Historical volume analysis: The report provides a comparison of Capsule OTC Analgesics's historical sales and projected sales performance for 2021-2031.
• Capsule OTC Analgesics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Capsule OTC Analgesics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
• Capsule OTC Analgesics Consumption by demographics: The report investigates consumer behavior affecting Capsule OTC Analgesics demand outlook for the assessment period. Effect of their keenness for digital trends on Capsule OTC Analgesics market is carefully analyzed
• Post COVID consumer spending on Capsule OTC Analgesics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Capsule OTC Analgesics market growth.

More Valuable Insights on Capsule OTC Analgesics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Capsule OTC Analgesics, Sales and Demand of Capsule OTC Analgesics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Explore Fact.MR's Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market - Global Industry Analysis and Opportunity Assessment 2021 - 2031 https://www.factmr.com/report/fluoro-enzymatic-assays-market

Shower Chairs Market - Global Industry Analysis and Opportunity Assessment 2021 - 2031 https://www.factmr.com/report/shower-chairs-market

Infrared Thermometer Market - Global Industry Analysis and Opportunity Assessment 2021 - 2031 https://www.factmr.com/report/infrared-thermometer-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About Fact.MR

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Capsule OTC Analgesics Market: Projection of Each Major Segment over the Forecast Period 2022 - 2032 here

News-ID: 2620061 • Views:

More Releases from Fact.MR

Global Data Catalog Market to Explode to $12.3 Billion by 2035, Driven by AI and Data Governance Mandates
Global Data Catalog Market to Explode to $12.3 Billion by 2035, Driven by AI and …
The global Data Catalog Market is undergoing a rapid, technology-driven transformation, shifting its role from a passive metadata repository to an intelligent, active data intelligence platform. Propelled by the exponential growth in complex data and regulatory demands, the market is projected to reach an estimated US$12.32 Billion by 2035, according to leading market analysis. This dramatic surge represents a Compound Annual Growth Rate (CAGR) of 21.9% throughout the forecast period of
Content Delivery Network (CDN) Market to Reach USD 45.2 Billion by 2035 | Akamai Technologies, Tata Communications, Microsoft Corporation, Alibaba Cloud, IBM Corporation, StackPath, Limelight Networks
Content Delivery Network (CDN) Market to Reach USD 45.2 Billion by 2035 | Akamai …
The latest report on the Content Delivery Network (CDN) Market, forecasting robust growth propelled by surging global data traffic, the proliferation of streaming services, and the escalating demand for low-latency digital experiences. Valued at USD 18.5 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 9.4%, reaching USD 45.2 billion by 2035. This trajectory reflects the indispensable role of CDNs in
Energy-based Aesthetic Devices Market Grow at a 10.8% CAGR by 2035 | Key Players: Cynosure, Lumenis Ltd., Alma Lasers Inc., Allergan Plc, Cutera, Merz Pharma GmbH & Co. KGaA
09-30-2025 | Health & Medicine
Fact.MR
Energy-based Aesthetic Devices Market Grow at a 10.8% CAGR by 2035 | Key Players …
latest report on the Energy-based Aesthetic Devices Market, forecasting robust growth propelled by surging demand for non-invasive dermatological treatments, technological innovations in laser, radiofrequency, ultrasound, and light-based systems, and heightened beauty awareness among consumers. Valued at USD 5,476.2 million in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 10.8%, reaching USD 15,180.4 million by 2035. This trajectory reflects the market's pivotal role
Global Surgical Tourniquets Market Projected to Nearly Triple, Reaching US$1.59 Billion by 2035
09-30-2025 | Health & Medicine
Fact.MR
Global Surgical Tourniquets Market Projected to Nearly Triple, Reaching US$1.59 …
The global surgical tourniquets market is poised for significant expansion over the next decade, driven by a global surge in orthopedic surgeries, heightened demand for safer intraoperative blood control, and major technological advancements in pressure regulation systems. According to a comprehensive analysis by Fact.MR, the market, valued at US 670 millionin 2025,is forecasted to grow at a steady Compound Annual Growth Rate(CAGR) of 91.59 billion. This robust growth trajectory is

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to